Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 1 2

Status

Recruiting 3Not yet recruiting 1

Sponsor Class

INDUSTRY 3OTHER 1

Study Type

Interventional 4

Sponsor

Cancer Type

Thoracic 4

Conditions

Small Cell Lung Carcinoma 3Extensive Stage Small Cell Lung Cancer 1

Interventions

Carboplatin 90pembrolizumab 73Pemetrexed 66Cisplatin 56atezolizumab 31Paclitaxel 31Docetaxel 30durvalumab 28Specimen Handling 26Nivolumab 26Magnetic Resonance Spectroscopy 21osimertinib 20Gemcitabine 19130-nm albumin-bound paclitaxel 18Etoposide 17Cetuximab 16Radiotherapy 14Platinum 131,2-diaminocyclohexaneplatinum II citrate 11amivantamab 10Taxes 10Immunoglobulin G 10Radiation 9PM 01183 9Ipilimumab 9Disulfides 9Bevacizumab 9Topotecan 8lazertinib 7fludarabine 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
AMG 757 × Thoracic × 30 days × Clear all
NCT07637513 2026-06-09

PrE0512

PrECOG, LLC.

Phase 3 Not yet recruiting
430 enrolled
Thoracic

Small Cell Lung Carcinoma

NCT07005128 2026-06-04

DeLLphi-312

Amgen

Phase 3 Recruiting
330 enrolled
Thoracic

Small Cell Lung Carcinoma

NCT06598306 2026-05-29

DeLLphi-308

Amgen

Phase 1 Recruiting
220 enrolled
Thoracic

Small Cell Lung Carcinoma

NCT07037758 2026-05-29

DeLLphi-311

Amgen

Phase 1 Recruiting
380 enrolled
Thoracic

Extensive Stage Small Cell Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡